SCHEMBL565185

SCHEMBL565185

CCCOC(=O)c1ccc(OCCC)c(I)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.57
CYP1A2 P05177 2/20 0.55
CYP2D6 P10635 2/20 0.55
SCN1A P35498 2/20 0.55
KCNH2 Q12809 2/20 0.55
SCN2A Q99250 2/20 0.55
SCN3A Q9NY46 2/20 0.55
HRH3 Q9Y5N1 2/20 0.55
CYP3A4 P08684 1/20 0.55
MAOA P21397 1/20 0.55
CYP2C19 P33261 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
KDM4E B2RXH2 1/20 0.55
POLB P06746 1/20 0.55
TSHR P16473 2/20 0.53
SLC6A2 P23975 2/20 0.53
ALDH1A1 P00352 2/20 0.53
CHRM1 P11229 1/20 0.53
KDR P35968 1/20 0.53
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27900739 0.89 KDM4E (0.60) ESR1CYP1A2CYP2D6SCN1AKCNH2
SCHEMBL15662814 0.88 MGLL (0.57) ESR1CYP1A2CYP2D6SCN1AKCNH2
SCHEMBL565936 0.86 POLB (0.63) ESR1CYP1A2CYP2D6SCN1AKCNH2
SCHEMBL566129 0.84 THRA (0.56) POLBTSHRALDH1A1THRATHRB
SCHEMBL12493009 0.83 CYP1A2 (0.56) ESR1CYP1A2CYP2D6SCN1AKCNH2
SCHEMBL3181546 0.82 HSD17B2 (0.54) ESR1CYP1A2CYP2D6SCN1AKCNH2
SCHEMBL4985115 0.81 CA12 (0.54) ESR1CYP1A2CYP3A4MAOATSHR
SCHEMBL27883417 0.81 ESR1 (0.68) ESR1CYP1A2CYP2D6SCN1AKCNH2
SCHEMBL18542253 0.81 ESR1 (0.56) ESR1POLBTSHRALDH1A1TDP1
SCHEMBL27041416 0.80 ESR1 (0.58) ESR1CYP1A2CYP2D6SCN1AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181182-B2 S1P receptors modulators AKAAL PHARMA PTY LTD (AU) 2015-11-10 US disclosed
US-20120034270-A1 S1P Receptors Modulators AKAAL PHARMA PTY LTD (AU) 2012-02-09 US disclosed
EP-2344446-A1 S1P RECEPTORS MODULATORS Akaal Pharma Pty Ltd (AU) 2011-07-20 EP disclosed
WO-2010042998-A1 S1P RECEPTORS MODULATORS AKAAL PHARMA PTY LTD (AU) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120034270-A1 S1P Receptors Modulators S1PR1, S1PR5, S1PR3 ESR1 1004/4885CYP1A2 4278/4885CYP2D6 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.